Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04214873 · ClinicalTrials.gov registry record · NA
Evaluation of the Effectiveness of the PiQo4 System for Reduction of Infra-orbital Pigmentation
A NA study, sponsored by Focus Medical.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04214873 is a NA study that has completed, run by Focus Medical. The registered enrollment target is 8 participants.
The verdict
NCT04214873, a NA study, has completed, sponsored by Focus Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
A total of 10 healthy subjects at a single site, aged 18-65 years old and Fitzpatrick skin type I-IV with mild to moderate infra-orbital hyperpigmentation on the background of epidermal and/or dermal pigmentation that wish to improve their POH
Interventions
- DEVICE PiQo4 Laser System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2022-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04214873
The ClinicalTrials.gov registry entry for NCT04214873 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Focus Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PiQo4 Laser System is the first listed.
NCT04214873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04214873 about?
NCT04214873 is a clinical study titled "Evaluation of the Effectiveness of the PiQo4 System for Reduction of Infra-orbital Pigmentation". A total of 10 healthy subjects at a single site, aged 18-65 years old and Fitzpatrick skin type I-IV with mild to moderate infra-orbital hyperpigmentation on the background of epidermal and/or dermal pigmentation that wish to improve their POH
What is the current status of trial NCT04214873?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2020-01-06. Estimated completion is 2022-01-20.
What interventions are being tested in trial NCT04214873?
The interventions under investigation include: PiQo4 Laser System (DEVICE).
Who is sponsoring clinical trial NCT04214873?
This trial is sponsored by Focus Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.